Introduction: Tobacco remains the key modifiable risk factor for the development of a number of diseases, including cardiovascular disease, cerebrovascular disease, lower respiratory infections, chronic obstructive pulmonary disease, tuberculosis and cancer. Among priority populations, smoking prevalence remains high, smokers tend to relapse more often and earlier and fewer are able to sustain quit attempts. This systematic review provides an update on the literature. Areas covered: Twenty-four randomized controlled trials published from 2010–2017, in English language, were identified after searching on Medline, Ovid, Embase and PsycINFO databases. Studies reported on the effectiveness of smoking cessation interventions among six disadvantaged groups known to have high smoking rates: (i) homeless, (ii) prisoners, (iii) indigenous populations, (iv) at-risk youth, (v) people with low income, and (vi) those with a mental illness. Narrative review and assessment of methodological quality of included papers was undertaken. Expert commentary: There is a growing evidence base of methodologically robust studies evaluating a variety of behavioural smoking cessation interventions for priority populations. Multi-component interventions and those examining behavioural interventions incorporating mindfulness training, financial incentives, motivational interviewing and extended telephone-delivered counseling may be effective in the short-term, particularly for smokers on low incomes and people with a mental illness.
History
Journal title
Expert Review of Respiratory Medicine
Volume
11
Issue
8
Pagination
617-630
Publisher
Taylor & Francis
Place published
Abingdon, UK
Language
en, English
College/Research Centre
Faculty of Health and Medicine
School
School of Nursing and Midwifery
Rights statement
This is an Accepted Manuscript of an article published by Taylor and Francis in the Expert Review of Respiratory Medicine on 21/06/2017, available online: https://www.tandfonline.com/doi/full/10.1080/17476348.2017.1340836.